Styptic composition

Details Styptic composition Styptic composition

A - Human Necessities

61

K

167/123

A61K 33/06 (2006.01) A61K 8/92 (2006.01) A61K 47/00 (2006.01)

Patent

CA 1102695

ABSTRACT OF THE DISCLOSURE An improved styptic composition which effectively curtails bleeding while administering a soothing sensation on the injured area. The styptic composition is in the form of a stable lotion or cream having the following general formula: 1) from about 2% to about 12% by weight of a long chain fatty acid; 2) from about 0.4% to about 3.5% by weight of a wax filler; 3) from about 1% to about 10% by weight of polyethylene glycol stearate; 4) from about 1% to about 5% by weight of polyethylene glycol sorbitan beeswax; and 5) from about 0.5% to about 25% by weight of an acidic metallic salt, 6) the balance being water. Optionally, from about 1% to about 4% by weight of glycerin may be added as a humectant. Any conventional antiseptic may also be added to the composition. The styptic composition may be packaged in any convenient form including jars, bottles, tubes, pump applicators, aerosol canisters and can also be impregnated into pre-packaged bandages.

309413

Affiliated with

Also associated with

Rating

Styptic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Styptic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Styptic composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1138216